Intragastric Balloon Market to Expand at a CAGR of 12.1% Through 2027

The global intragastric balloon market size is expected to reach USD 90.5 million by 2027, expanding at a CAGR of 12.1% over the forecast period, according to a new report by Grand View Research, Inc. Rise in obesity and increasing demand for minimally invasive procedures are the key factors driving the market.

Intragastric balloons are one of the most widely adopted endoscopic bariatric therapy devices in the clinical settings. This can be attributed to complications associated with surgical weight loss treatments and the low eligibility criteria for surgical options, thus leading to a rise in demand for effective minimally invasive weight-loss treatment options.

Safety concerns associated with intragastric balloons are anticipated to make the regulatory framework more stringent for pre-market and post-market scrutiny process of these devices. For instance, in 2019, Apollo Endosurgery Inc. revised the labeling of its Orbera intragastric balloon system to include contradiction clarifications, precautions related to anticholinergic and psychotropic medications, and updated U.S. adverse event tables after it received FDA safety letter.

Nonetheless, extensive research activities related to the development of innovative and novel systems and up-gradation of existing intragastric balloons to overcome the shortcomings of the traditional systems are anticipated to facilitate the intragastric balloon market growth.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/intragastric-balloon-market

Further key findings from the study suggest:

• According to the American Society for Metabolic and Bariatric Surgery (ASMBS) data, nearly 5,000 intragastric balloon implantations have been conducted since the U.S. FDA approval
• The single balloon type segment held the largest share in the market in 2019. The triple type is expected to witness significant growth over the forecast period
• By filling material, gas-filled systems are anticipated to witness lucrative growth over the forecast period
• Based on end use, hospitals held a significant share in 2019. Ambulatory surgical centers are expected to witness considerable growth from 2020 - 2027
• On the basis of administration, endoscopy held the dominant market share in 2019. Pill form is expected to witness lucrative growth over the forecast period
• North America dominated the intragastric balloon market in 2019 due to the presence of a large obese population and high adoption of bariatric procedures. Asia Pacific is expected to witness remunerative growth over the forecast period
• Some of the key companies operating in the market are Apollo Endosurgery, Inc.; Obalon Therapeutics, Inc; ReShape Medical, Inc; Allurion Technologies, Inc.; Spatz3; Helioscopie; Endalis; MEDSIL; and Lexel Medical
• As of January 2019, Apollo Endosurgery, Inc. has discontinued the sales and distribution of its ReShape Balloon.

Grand View Research has segmented the global intragastric balloon market on the basis of administration, balloon type, filling material, end use, and region:

Intragastric Balloon Administration Outlook (Revenue, USD Million, 2016 - 2027)

• Pill Form
• Endoscopy

Intragastric Balloon Type Outlook (Revenue, USD Million, 2016 - 2027)

• Single
• Dual
• Triple

Intragastric Balloon Filling Material Outlook (Revenue, USD Million, 2016 - 2027)

• Saline Filled
• Gas Filled

Intragastric Balloon End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Clinics
• Ambulatory Surgical Centers

Intragastric Balloon Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • The Netherlands
  • Belgium
  • Switzerland
  • Turkey
  • Poland
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
• MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.